2009-11-13 18:19:04 -
Jazz Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/jazz-pharmac ..
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) extended-release capsules and JZP-6 (sodium oxybate). The other product candidates in clinical development are JZP-8 (intranasal clonazepam), being developed for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens, JZP-4 (sodium and calcium channel antagonist), being developed for the treatment of epilepsy and bipolar disorder, and JZP-7 (ropinirole gel), being developed for the treatment of restless legs syndrome. More from Reuters »
Jazz Pharmaceuticals, Inc. -
Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Jazz Pharmaceuticals, Inc. (Jazz) is a pharmaceutical company engaged in identifying, developing, and commercializing products for neurology and psychiatry. The companys products list include Xyrem, for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy, Antizol and Luvox CR, an extended release formulation of fluvoxaminefor, which is a selective serotonin reuptake inhibitor for the treatment of obsessive compulsive disorder and social anxiety disorder. The companys clinical development pipeline comprises JZP-4, JZP-6, JZP-7 and JZP-8. The company has its operation spreads across the world including the US, Europe, Asia and Africa.
The Jazz Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
